Table 2.
Baseline demographics and clinical characteristics of patients
| IN group | C group | p | |
|---|---|---|---|
| Demographic profile | |||
| Age (years) | 68.3 ± 6.9 | 71.0 ± 5.4 | 0.112 |
| Sex: | |||
| Male, n (%) | 14 (51.9) | 14 (50.0) | 0.891 |
| Female, n (%) | 13 (48.1) | 14 (50.0) | |
| Body mass index (kg/m2) | 28.6 ± 5.1 | 27.8 ± 4.5 | 0.550 |
| Phase angle (0) | 5.2 [5.04–5.32] | 5.11 [4.72–5.30] | 0.117 |
| Comorbidities | |||
| NYHA classification: | >0.05 | ||
| Class II, n (%) | 3 (11.1) | 0 (0) | |
| Class III, n (%) | 24 (88.9) | 28 (100.0) | |
| Class I and IV, n (%) | 0 (0) | 0 (0) | |
| ASA physical status | |||
| ASA III, n (%) | 27 (100.0) | 28 (100.0) | >0.05 |
| CCI | 3 [2.00–4.00] | 3 [3.00–3.75] | 0.570 |
| Arterial hypertension, n (%) | 23 (85.2) | 26 (92.9) | 0.362 |
| Renal failure, n (%) | 2 (7.4) | 1 (3.6) | 0.531 |
| Myocardial infarction, n (%) | 9 (33.3) | 5 (17.9) | 0.188 |
| Diabetes, n (%) | 7 (25.9) | 7 (25.0) | 0.937 |
| Operative characteristics | |||
| EuroScore II (%) | 1.97 ± 0.8 | 1.99 ± 0.8 | 0.918 |
| Operation type: | >0.05 | ||
| CABG, n (%) | 17 (63.0) | 18 (64.3) | |
| Aortic valve, n (%) | 4 (14.8) | 4 (14.3) | |
| Mitral valve, n (%) | 3 (11.1) | 1 (3.6) | |
| Tricuspid valve, n (%) | 1 (3.7) | 0 (0) | |
| Combined, n (%) | 3 (11.1) | 5 (17.8) | |
| Aortic cross-clamp time (min) | 75.5 ± 29.3 | 75.2 ± 25.4 | 0.966 |
| CPB time (min) | 112.6 ± 39.3 | 109.2 ± 34.2 | 0.735 |
| Operation time (min) | 257.4 ± 73.5 | 258.75 ± 62.4 | 0.944 |
NYHA – New York Heart Association; CABG – coronary artery bypass grafting; ASA – American Society of Anesthesiologists; CCI – Charlson comorbidity index
Mean value and standard deviation (mean ± SD); median and interquartile range (median [IQR]); p value